The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Research Report 2024
Synopsis
DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, which is given to children. DT (diphtheria and tetanus) vaccine, which is given to children. Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine, which is given to adolescents and adults.
The global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market was valued at US$ 5315 million in 2023 and is anticipated to reach US$ 6874.5 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Increasing awareness about the importance of vaccination, growing incidence of diphtheria, tetanus, and pertussis infections, and government immunization programs are key drivers of market expansion. Advancements in vaccine technology, such as the development of acellular pertussis vaccines, have improved safety and efficacy, further boosting market growth. Additionally, the introduction of combination vaccines that provide protection against multiple diseases has simplified immunization schedules and increased convenience for healthcare providers and patients. However, challenges such as vaccine hesitancy, high manufacturing costs, and limited accessibility in certain regions may hinder market growth.
This report aims to provide a comprehensive presentation of the global market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine.
Report Scope
The Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
KM Biologics
Serum Institute of India
Walvax Biotechnology
Sinopharm
Segment by Type
DTaP
Tdap
Segment by Application
Child
Adult
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, which is given to children. DT (diphtheria and tetanus) vaccine, which is given to children. Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine, which is given to adolescents and adults.
The global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market was valued at US$ 5315 million in 2023 and is anticipated to reach US$ 6874.5 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Increasing awareness about the importance of vaccination, growing incidence of diphtheria, tetanus, and pertussis infections, and government immunization programs are key drivers of market expansion. Advancements in vaccine technology, such as the development of acellular pertussis vaccines, have improved safety and efficacy, further boosting market growth. Additionally, the introduction of combination vaccines that provide protection against multiple diseases has simplified immunization schedules and increased convenience for healthcare providers and patients. However, challenges such as vaccine hesitancy, high manufacturing costs, and limited accessibility in certain regions may hinder market growth.
This report aims to provide a comprehensive presentation of the global market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine.
Report Scope
The Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
KM Biologics
Serum Institute of India
Walvax Biotechnology
Sinopharm
Segment by Type
DTaP
Tdap
Segment by Application
Child
Adult
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Overview
1.1 Product Overview and Scope of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine
1.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Segment by Type
1.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 DTaP
1.2.3 Tdap
1.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Segment by Application
1.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Value by Application: (2024-2030)
1.3.2 Child
1.3.3 Adult
1.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Estimates and Forecasts
1.4.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue 2019-2030
1.4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales 2019-2030
1.4.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Competition by Manufacturers
2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Product Type & Application
2.7 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Competitive Situation and Trends
2.7.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Market Share by Revenue
2.7.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Retrospective Market Scenario by Region
3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region: 2019-2030
3.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region: 2019-2024
3.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region: 2025-2030
3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region: 2019-2030
3.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region: 2019-2024
3.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region: 2025-2030
3.4 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Facts & Figures by Country
3.4.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2019-2030)
3.4.3 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Facts & Figures by Country
3.5.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2019-2030)
3.5.3 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Facts & Figures by Country
3.7.1 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2019-2030)
4.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2019-2024)
4.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2025-2030)
4.1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2019-2030)
4.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2019-2024)
4.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2025-2030)
4.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2019-2030)
5.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2019-2024)
5.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2025-2030)
5.1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2019-2030)
5.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2019-2024)
5.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2025-2030)
5.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 KM Biologics
6.3.1 KM Biologics Corporation Information
6.3.2 KM Biologics Description and Business Overview
6.3.3 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
6.3.5 KM Biologics Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Corporation Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Sinopharm
6.6.1 Sinopharm Corporation Information
6.6.2 Sinopharm Description and Business Overview
6.6.3 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
6.6.5 Sinopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Chain Analysis
7.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Production Mode & Process
7.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Marketing
7.4.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Channels
7.4.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors
7.5 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Customers
8 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Dynamics
8.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Trends
8.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers
8.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges
8.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
